Chronicle Journal: Finance

U.S Bullish and Most Traded Stocks: $FEAC $ZOM $LONE

The Market Signal was created as a platform to help investors, if you own (NYSE:FEAC), (NYSE:ZOM) or (NASDAQ:LONE) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Flying Eagle Acquisition is bullish as it seeks to combines its business with Skillz Inc

https://themarketsignal.com/Free-Report/FEAC

(Click link above or copy, paste and hit enter in your browser for your report)

Flying Eagle Acquisition Corp. (NYSE:FEAC) gained 27.45% on a volume of 45.83 million shares

Flying Eagle Acquisition Corp and Skillz Inc are combining their businesses that will see Skillz becoming a publicly-listed company. Flying Eagle Acquisition Corp. a publicly-traded special purpose acquisition company while Skillz Inc is a leading game developer that connects players in fair, fun, and meaningful competition.

Several investors like Neuberger Berman, Franklin Templeton, Fidelity, and Wellington have committed more than 250 million in the listed company.

Zomedica Pharmaceuticals is risk-free as it launches its TRUFORMA with five assays

https://themarketsignal.com/Free-Report/ZOM

(Click link above or copy, paste and hit enter in your browser for your report)

Zomedica Pharmaceuticals Corp. (NYSE:ZOM) gained 9.17% on a volume of 43.94 million shares

Zomedica Pharmaceuticals Corp intends to launch its TRUFORMA with five assays and is expected to be a major contributor to the veterinarian's practice, both economically and clinically. This is means the company is essentially undertaking five projects simultaneously which is a very huge investment. The company partnered with a subsidiary of Qorvo, Inc and successfully verified three of the assays. The two companies are working on the remaining work.

At the close of Q2 2020, Zomedica Pharmaceuticals had over US $50 million in cash and cash equivalents. The company has enough cash to take it beyond TRUFORMA commercialization.

Lonestar Resources US is bullish as it secures extension of its debt agreement

https://themarketsignal.com/Free-Report/LONE

(Click link above or copy, paste and hit enter in your browser for your report)

Lonestar Resources US Inc. (NASDAQ:LONE) gained 39.09% on a volume of 43.09 million shares

Lonestar Resources has struck a deal with holders of outstanding 11.25% senior notes due 2023 to Sept. 11 to extend its forbearance agreement. This according to the company's latest 8-K filing. The company had initially extended its forbearance agreement to Aug. 21. The company failed to make a July 1 $14M interest payment on the notes which made it a defaulter at the time.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_370630498/2700/2020-09-03T08:33:01

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.